Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Needham analyst Gil Blum upgraded Amicus Therapeutics, Inc. (NASDAQ:FOLD) from Hold to Buy and announced a $14 price target. Amicus Therapeutics shares closed at $7.97 on Wednesday. See how other analysts view this stock.
- RBC Capital analyst Walter Spracklin upgraded the rating for CSX Corporation (NASDAQ:CSX) from Sector Perform to Outperform and boosted the price target from $37 to $39. CSX shares closed at $32.77 on Wednesday. See how other analysts view this stock.
- Scotiabank analyst Alfonso Salazar upgraded Vale S.A. (NYSE:VALE) from Sector Perform to Sector Outperform and announced a $14 price target. Vale shares closed at $10.88 on Wednesday. See how other analysts view this stock.
- RBC Capital analyst Piral Dadhania upgraded the rating for NIKE, Inc. (NYSE:NKE) from Sector Perform to Outperform and raised the price target from $76 to $90. Nike shares closed at $72.31 on Wednesday. See how other analysts view this stock.
- JP Morgan analyst Lisa Gill upgraded Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) from Underweight to Neutral and increased the price target from $6 to $10. Aveanna Healthcare shares closed at $8.08 on Wednesday. See how other analysts view this stock.
Considering buying CSX stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
